Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GLP 1 Analogues. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel GLP-1 analogues with extended half-life via microwave solid-phase synthesis. Stable, high-purity pharmaceutical intermediates for diabetes treatment.
Patent CN103087177A details microwave-assisted solid-phase synthesis of stable GLP-1 analogues with extended half-life, offering cost-effective manufacturing solutions.